Clinical Trial Update: Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM) [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating prevention of disease progression in early-stage indolent B-cell malignancies (MGUS, smoldering multiple myeloma, and chronic lymp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Monoclonal Gammopathy of Undetermined Significance
• Smoldering Multiple Myeloma

Snippet

Sponsor: Marshall University | Conditions: Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma | Phase 2 | Status: TERMINATED | Results posted: 2013-11-18